Selective Serotonin Reuptake Inhibitor (SSRI) updated on 07-01-2025

Low Apgar score (< 7) (at 1 min)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S18442
R78278
Lee (Controls exposed to TCAs), 2025 1-minute Apgar score <7 during pregnancy (anytime or not specified) retrospective cohort (claims database) exposed to other treatment, sick excluded Adjustment: No Monotherapy: SSRI only 0.89 [0.59;1.36] C
excluded (control group)
73/1,465   34/613 107 1,465
ref
S18408
R77700
Lee (Controls unexposed, general pop), 2025 1-minute Apgar score <7 during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: Yes Monotherapy: SSRI only 1.41 [1.09;1.82] 73/1,465   14,883/463,440 14,956 1,465
ref
S14995
R61358
Lyn, 2023 1 min Apgar score of less than seven during pregnancy (anytime or not specified) retrospective cohort unexposed (general population or NOS) Adjustment: No Monotherapy: no or not specified 2.11 [0.97;4.58] -/130   -/259 - 130
ref
S7569
R22725
Hogue, 2017 1-minute Apgar score less than 7 (in full-term neonates) during pregnancy (anytime or not specified) retrospective cohort unexposed (general population or NOS) Adjustment: Yes Monotherapy: SSRI only 3.60 [1.06;12.50] 15/117   6/116 21 117
ref
S13007
R49379
Bakaysa, 2016 Low APGAR scores at 1 minute (< 7) late pregnancy retrospective cohort unexposed (general population or NOS) Adjustment: No Monotherapy: no or not specified 2.00 [1.10;3.50] 27/112   32/224 59 112
ref
S7570
R22764
Kivistö, 2016 Low (<7) Apgar score at 1 min during pregnancy (anytime or not specified) retrospective cohort unexposed (general population or NOS) Adjustment: Yes Monotherapy: SSRI only 2.29 [1.65;3.18] 51/358   1,451/24,402 1,502 358
ref
S5408
R16601
Wisner (Controls unexposed, disease free), 2009 Apgar Score ≤7 at 1 minute throughout pregnancy prospective cohort unexposed, disease free excluded Adjustment: No Monotherapy: no or not specified 1.33 [0.53;3.32] C
excluded (control group)
8/48   17/130 25 48
ref
S6249
R16609
Wisner (Controls unexposed, sick), 2009 Apgar Score ≤7 at 1 minute throughout pregnancy prospective cohort unexposed, sick Adjustment: No Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 0.73 [0.17;3.24] C 8/48   3/14 11 48
ref
Total 6 studies 1.84 [1.38;2.46] 16,549 2,230
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Lee (Controls unexposed, general pop), 2025Lee, 2025 1 1.41[1.09; 1.82]14,9561,46535%ROB confusion: moderateROB selection: lowROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Lyn, 2023Lyn, 2023 2.11[0.97; 4.58]-13011%ROB confusion: criticalROB selection: criticalROB classification: unclearROB missing: unclearROB mesure: unclearROB reporting: moderate Hogue, 2017Hogue, 2017 3.60[1.06; 12.50]211175%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA Bakaysa, 2016Bakaysa, 2016 2.00[1.10; 3.50]5911216%ROB confusion: criticalROB selection: unclearROB classification: unclearROB missing: unclearROB mesure: unclearROB reporting: moderate Kivistö, 2016Kivistö, 2016 2.29[1.65; 3.18]1,50235830%ROB confusion: seriousROB selection: criticalROB classification: moderateROB missing: criticalROB mesure: moderateROB reporting: moderate Wisner (Controls unexposed, sick), 2009Wisner, 2009 2 0.73[0.17; 3.24]11484%ROB confusion: criticalROB selection: lowROB classification: lowROB missing: lowROB mesure: moderateROB reporting: moderate Total (6 studies) I2 = 40% 1.84[1.38; 2.46]16,5492,2300.210.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, general pop; 2: Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.84[1.38; 2.46]16,5492,23040%NALee (Controls unexposed, general pop), 2025 Lyn, 2023 Hogue, 2017 Bakaysa, 2016 Kivistö, 2016 Wisner (Controls unexposed, sick), 2009 6 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.90[1.42; 2.54]16,5382,18243%NALee (Controls unexposed, general pop), 2025 Lyn, 2023 Hogue, 2017 Bakaysa, 2016 Kivistö, 2016 5 unexposed, sickunexposed, sick 0.73[0.17; 3.24]1148 -NAWisner (Controls unexposed, sick), 2009 1 Tags Adjustment   - No  - No 1.86[1.20; 2.90]702900%NALyn, 2023 Bakaysa, 2016 Wisner (Controls unexposed, sick), 2009 3   - Yes  - Yes 1.92[1.22; 3.01]16,4791,94070%NALee (Controls unexposed, general pop), 2025 Hogue, 2017 Kivistö, 2016 3 Monotherapy   - no or not specified  - no or not specified 1.86[1.20; 2.90]702900%NALyn, 2023 Bakaysa, 2016 Wisner (Controls unexposed, sick), 2009 3   - SSRI only  - SSRI only 1.92[1.22; 3.01]16,4791,94070%NALee (Controls unexposed, general pop), 2025 Hogue, 2017 Kivistö, 2016 3 Unexposed sick   - recent illness/treatment (during o ...  - recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 0.73[0.17; 3.24]1148 -NAWisner (Controls unexposed, sick), 2009 1 All studiesAll studies 1.84[1.38; 2.46]16,5492,23040%NALee (Controls unexposed, general pop), 2025 Lyn, 2023 Hogue, 2017 Bakaysa, 2016 Kivistö, 2016 Wisner (Controls unexposed, sick), 2009 60.210.01.0

Publication bias and p-hacking diagnosis

funnel plot
0.0-1.82.40.9090.000Lee (Controls unexposed, general pop), 2025Lyn, 2023Hogue, 2017Bakaysa, 2016Kivistö, 2016Wisner (Controls unexposed, sick), 2009

Asymetry test p-value = 0.6541 (by Egger's regression)

slope=0.4581 (0.2472); intercept=0.5260 (1.0884); t=0.4833; p=0.6541

p values plot
0.01.00.01.0

Sub-groups analysis using all included studies

excluded 5408, 18442

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.84[1.42; 2.37]16,5632,23032%NALee (Controls unexposed, general pop), 2025 Lyn, 2023 Hogue, 2017 Bakaysa, 2016 Kivistö, 2016 Wisner (Controls unexposed, disease free), 2009 6 unexposed, sick controlsunexposed, sick controls 0.73[0.17; 3.24]1148 -NAWisner (Controls unexposed, sick), 2009 1 exposed to other treatment, sick controlsexposed to other treatment, sick controls 0.89[0.59; 1.36]1071,465 -NALee (Controls exposed to TCAs), 2025 10.510.01.0

Umbrella review (other published meta-analyses)

Published MAControlPeriodTE95% CIn exposedkI2 Wang - SSRI (Apgar - 1min <= 7)Wang - SSRI (Apgar - 1min <= 7) 1.55[1.04; 2.29]0%-Wwhatever (meta-analysis)T33rd trimesterstudies TTT2 metaPregmetaPreg 1.84[1.38; 2.46]40%2,230----Lee (Controls unexposed, general pop), 2025 Lyn, 2023 Hogue, 2017 Bakaysa, 2016 Kivistö, 2016 Wisner (Controls unexposed, sick), 2009 60.510.01.0